Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel - PubMed (original) (raw)
Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel
George Z Cheng et al. Cancer Res. 2007.
Abstract
Metastasis, the cardinal feature of malignant tumors, is an important clinical variable in patient prognosis. To understand the basis for metastasis, we systematically selected for highly invasive cells from breast cancer cell lines, MCF7 and MDA-MB-453, with moderate to low invasive ability using Boyden chamber invasion assay. The four-cycle selected invasive lines, named MCF7-I4 and MDA-MB-453-I4, respectively, displayed epithelial-mesenchymal transition (EMT) and dramatically enhanced invasive ability. EMT changes were corroborated with decreased level of E-cadherin and increased vimentin, fibronectin, and beta(1) integrin. Twist, a basic helix-loop-helix transcription factor, and AKT2, a known proto-oncogene, were found to be elevated in the invasive cells compared with the parental. Ectopic expression and knockdown of Twist by short interference RNA resulted in significant increase and reduction, respectively, of AKT2 protein and mRNA expression. Twist bound to E-box elements on AKT2 promoter and enhanced its transcriptional activity. Moreover, silencing AKT2 decreased Twist-promoted migration, invasion, and paclitaxel resistance. Reintroducing AKT2 largely rescued the phenotype resulted from knockdown of Twist in I4 cells, suggesting that AKT2 is a downstream target and functional mediator of Twist. Finally, we observed a 68.8% correlation of elevated Twist and AKT2 expression in late-stage breast cancers as oppose to 13% in early-stage breast cancers. Our study identifies Twist as a positive transcriptional regulator of AKT2 expression, and Twist-AKT2 signaling is involved in promoting invasive ability and survival of breast cancer cells.
Similar articles
- Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function.
Cheng GZ, Zhang WZ, Sun M, Wang Q, Coppola D, Mansour M, Xu LM, Costanzo C, Cheng JQ, Wang LH. Cheng GZ, et al. J Biol Chem. 2008 May 23;283(21):14665-73. doi: 10.1074/jbc.M707429200. Epub 2008 Mar 19. J Biol Chem. 2008. PMID: 18353781 Free PMC article. - Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
Khan MA, Tania M, Wei C, Mei Z, Fu S, Cheng J, Xu J, Fu J. Khan MA, et al. Oncotarget. 2015 Aug 14;6(23):19580-91. doi: 10.18632/oncotarget.3973. Oncotarget. 2015. PMID: 26023736 Free PMC article. - STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Zhang C, Guo F, Xu G, Ma J, Shao F. Zhang C, et al. Oncol Rep. 2015 Apr;33(4):1872-82. doi: 10.3892/or.2015.3783. Epub 2015 Feb 4. Oncol Rep. 2015. PMID: 25653024 - Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay.
Cheng GZ, Zhang W, Wang LH. Cheng GZ, et al. Cancer Res. 2008 Feb 15;68(4):957-60. doi: 10.1158/0008-5472.CAN-07-5067. Cancer Res. 2008. PMID: 18281467 Review. - Implications of Akt2/Twist crosstalk on breast cancer metastatic outcome.
Pereira L, Horta S, Mateus R, Videira MA. Pereira L, et al. Drug Discov Today. 2015 Sep;20(9):1152-8. doi: 10.1016/j.drudis.2015.06.010. Epub 2015 Jun 29. Drug Discov Today. 2015. PMID: 26136161 Review.
Cited by
- Glycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition?
da Fonseca LM, da Silva VA, Freire-de-Lima L, Previato JO, Mendonça-Previato L, Capella MA. da Fonseca LM, et al. Front Oncol. 2016 Jun 22;6:158. doi: 10.3389/fonc.2016.00158. eCollection 2016. Front Oncol. 2016. PMID: 27446804 Free PMC article. Review. - Paclitaxel Promotes Tumor-Infiltrating Macrophages in Breast Cancer.
Shen J, Chen C, Li Z, Hu S. Shen J, et al. Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820945821. doi: 10.1177/1533033820945821. Technol Cancer Res Treat. 2020. PMID: 32783527 Free PMC article. - Copper-Dependent Kinases and Their Role in Cancer Inception, Progression and Metastasis.
Vitaliti A, De Luca A, Rossi L. Vitaliti A, et al. Biomolecules. 2022 Oct 20;12(10):1520. doi: 10.3390/biom12101520. Biomolecules. 2022. PMID: 36291728 Free PMC article. Review. - Role of N-Cadherin in Epithelial-to-Mesenchymal Transition and Chemosensitivity of Colon Carcinoma Cells.
Skarkova V, Vitovcova B, Matouskova P, Manethova M, Kazimirova P, Skarka A, Brynychova V, Soucek P, Vosmikova H, Rudolf E. Skarkova V, et al. Cancers (Basel). 2022 Oct 20;14(20):5146. doi: 10.3390/cancers14205146. Cancers (Basel). 2022. PMID: 36291930 Free PMC article. - Special AT-rich sequence binding protein 1 regulates the multidrug resistance and invasion of human gastric cancer cells.
Sun F, Lu X, Li H, Peng Z, Wu K, Wang G, Tong Q. Sun F, et al. Oncol Lett. 2012 Jul;4(1):156-162. doi: 10.3892/ol.2012.681. Epub 2012 Apr 17. Oncol Lett. 2012. PMID: 22807980 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous